PhotoDashboard
JBSA Photo Gallery
JOINT BASE SAN ANTONIO-FORT SAM HOUSTON (Dec. 8, 2025) Dr. Jeremy Pamplin, (center) program manager, Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), examines the method by which research scientists at Naval Medical Research Unit (NAMRU) San Antonio assess a wide range of inflammatory biomarkers in biological samples in support of DARPA’s Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program at the Battlefield Health & Trauma Research Institute. NAMRU San Antonio serves as the Independent Validation & Verification partner for the FSHARP program to perform laboratory testing for safety and efficacy. The FSHARP program works to develop a deployable, shelf-stable, universal whole blood substitute as a hemorrhage countermeasure to sustain injured warfighters in austere, pre-hospital settings. NAMRU San Antonio, part of Navy Medicine Research & Development, works alongside research partners in the civilian sphere, academia, industry, and other government agencies to drive support of the Department of War’s objectives for a lethal fighting force and ensures U.S. service members have access to the latest scientific advances. NAMRU San Antonio conducts gap-driven combat casualty care, craniofacial, and directed energy research in support of Navy, Marine Corps and joint U.S. warfighter health readiness and lethality while engaged in routine and expeditionary operations. (U.S. Navy photo by Burrell Parmer/Released)
251208-N-ND850-1004.JPG Photo By: Burrell Parmer

San Antonio, TX - JOINT BASE SAN ANTONIO-FORT SAM HOUSTON (Dec. 8, 2025) Dr. Jeremy Pamplin, (center) program manager, Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), examines the method by which research scientists at Naval Medical Research Unit (NAMRU) San Antonio assess a wide range of inflammatory biomarkers in biological samples in support of DARPA’s Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program at the Battlefield Health & Trauma Research Institute. NAMRU San Antonio serves as the Independent Validation & Verification partner for the FSHARP program to perform laboratory testing for safety and efficacy. The FSHARP program works to develop a deployable, shelf-stable, universal whole blood substitute as a hemorrhage countermeasure to sustain injured warfighters in austere, pre-hospital settings. NAMRU San Antonio, part of Navy Medicine Research & Development, works alongside research partners in the civilian sphere, academia, industry, and other government agencies to drive support of the Department of War’s objectives for a lethal fighting force and ensures U.S. service members have access to the latest scientific advances. NAMRU San Antonio conducts gap-driven combat casualty care, craniofacial, and directed energy research in support of Navy, Marine Corps and joint U.S. warfighter health readiness and lethality while engaged in routine and expeditionary operations. (U.S. Navy photo by Burrell Parmer/Released)


DOWNLOAD PHOTO (1.77 MB)


This photograph is considered public domain and has been cleared for release. If you would like to republish please give the photographer appropriate credit. Further, any commercial or non-commercial use of this photograph or any other DoD image must be made in compliance with guidance found at http://www.dimoc.mil/resources/limitations.html , which pertains to intellectual property restrictions (e.g., copyright and trademark, including the use of official emblems, insignia, names and slogans), warnings regarding use of images of identifiable personnel, appearance of endorsement, and related matters.



Back to Gallery